Aetna's $117.7 Million Settlement for Inaccurate Medicare Codes

Aetna’s $117.7 million settlement over Medicare Advantage diagnosis coding highlights a growing compliance spotlight that every insurance carrier, agency, and healthcare-adjacent organization should be paying attention to.

Federal regulators continue to intensify scrutiny of the Medicare Advantage program, and the latest settlement involving Aetna underscores just how significant the stakes have become. The agreement resolves allegations that the insurer submitted inaccurate diagnosis codes that led to inflated payments from the federal government. While the settlement does not include an admission of wrongdoing, it reflects mounting regulatory pressure surrounding risk adjustment practices across the Medicare Advantage ecosystem.

For insurance professionals, particularly those working with Medicare products or advising senior clients, the case offers a timely reminder that accurate data reporting is not simply a back office function. It is a central component of program integrity and financial accountability.

Why Medicare Advantage Coding Matters

Medicare Advantage plans operate under a payment system designed to ensure insurers are compensated appropriately for caring for beneficiaries with varying health conditions. The Centers for Medicare and Medicaid Services adjusts payments based on risk scores, which are calculated using diagnosis codes submitted by insurers.

These codes originate from healthcare providers who document patient conditions during medical encounters. When those conditions indicate more complex or costly care needs, the risk score increases and monthly payments from CMS increase accordingly.

The system is designed to prevent insurers from avoiding higher risk patients and to ensure plans have adequate funding to manage chronic or severe health conditions. However, the model also creates strong incentives to capture as many qualifying diagnoses as possible.

According to federal officials, Medicare Advantage now accounts for more than half of all Medicare enrollment, with insurers receiving more than $530 billion annually in federal payments tied to these risk scores. That scale has placed the program squarely under the microscope of regulators and enforcement agencies.

“Accurate diagnosis coding is essential to protecting the integrity of the Medicare Advantage program and ensuring taxpayer dollars are spent appropriately.”

Scott J. Lampert, U.S. Department of Health and Human Services Office of Inspector General

What the Settlement Alleged

Federal investigators alleged that Aetna submitted diagnosis codes that were not fully supported by medical documentation, resulting in higher payments from CMS than the insurer was entitled to receive.

A large portion of the settlement relates to chart review practices used in 2015. Chart reviews involve analyzing patient medical records to identify diagnoses that may not have been submitted originally. When legitimate, the process helps ensure risk scores accurately reflect a patient's health status.

However, regulators alleged that certain codes identified during these reviews were not actually documented by treating providers. Those codes were then submitted to CMS, increasing the calculated risk score and the resulting payments.

An additional portion of the settlement addresses claims submitted between 2018 and 2023. In those instances, the government alleged that unsupported diagnoses such as morbid obesity were reported without adequate medical documentation.

The Department of Justice stated that these submissions resulted in improper payments under the federal False Claims Act framework, which prohibits entities from knowingly submitting inaccurate claims for government reimbursement.

Risk Adjustment Under the Compliance Microscope

The Aetna settlement reflects a broader trend that has been developing for years. Risk adjustment practices within Medicare Advantage have become a central enforcement focus for federal regulators.

Government agencies, including the Department of Justice and the Department of Health and Human Services Office of Inspector General, have steadily increased investigations into how insurers document and report patient conditions.

Industry analysts note that the complexity of the risk adjustment model can create operational challenges. Accurate coding requires close coordination among physicians, medical record systems, compliance teams, and insurers. Even minor documentation inconsistencies can create compliance exposure.

For insurers managing millions of members across thousands of providers, maintaining consistent documentation standards across that network becomes an enormous operational undertaking.

“Private insurers receive hundreds of billions of dollars each year to provide care through Medicare Advantage, and the Department of Justice will continue to pursue improper reimbursement practices.”

Brett A. Shumate, Assistant Attorney General

What Insurance Professionals Should Take Away

While the case primarily centers on a large national carrier, the implications extend across the entire insurance ecosystem. Agencies, carriers, and organizations working within Medicare related markets should expect continued scrutiny of documentation, reporting practices, and risk adjustment methodologies.

Several themes are emerging as regulators intensify oversight.

Key Compliance Signals

• Data accuracy matters more than ever: Diagnosis codes must align directly with documented clinical evidence and provider reporting.
• Chart reviews face closer examination: Retrospective coding reviews are being evaluated for documentation integrity.
• Federal enforcement is expanding: Risk adjustment investigations are becoming a major focus for regulators.
• Operational transparency is critical: Insurers must demonstrate clear compliance processes across provider networks.

The Growing Scale of Medicare Advantage

The attention surrounding risk adjustment practices is directly tied to the explosive growth of Medicare Advantage enrollment. Over the past decade, the program has evolved from a supplemental option into the dominant form of Medicare coverage.

Today more than half of Medicare beneficiaries are enrolled in private Medicare Advantage plans. That rapid growth has amplified the financial scale of the program and increased the importance of maintaining accurate payment systems.

For insurers, Medicare Advantage represents a significant revenue stream and a core component of long term strategy. For regulators, the size of those payments raises important questions about oversight and accountability.

Settlements like the one involving Aetna demonstrate that regulators intend to ensure that risk adjustment mechanisms function exactly as designed.

A Compliance Era for Medicare Programs

Industry observers widely expect additional enforcement activity in the coming years as federal agencies continue auditing risk adjustment data across the Medicare Advantage landscape.

For insurance carriers and agencies working with Medicare products, the message is clear. Documentation integrity, coding accuracy, and compliance oversight are becoming defining operational priorities in the evolving regulatory environment.

As the Medicare Advantage program continues to expand, maintaining confidence in the accuracy of its payment structure will remain a central focus for regulators, insurers, and the broader healthcare system.